UNIVERSITY OF MIAMI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b
Not Applicable
- Conditions
- Medication AdherenceMental Health Issue
- Interventions
- Behavioral: CBT for Syndemics and Adherence Factors
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 75
- Registration Number
- NCT05352061
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
SpeakFree Heat and Moisture Exchanger (HME)
Not Applicable
Completed
- Conditions
- LaryngectomyLaryngeal Cancer
- Interventions
- Device: SpeakFree HME Hands Free ValveOther: Digital OcclusionDevice: Digital Depression HME
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 18
- Registration Number
- NCT05349487
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Phase 2
Terminated
- Conditions
- Post Inflammatory HyperpigmentationAcne
- Interventions
- Other: SunscreenDrug: Liftactiv B3
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 13
- Registration Number
- NCT05327361
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
Not Applicable
Withdrawn
- Conditions
- Constipation-predominant Irritable Bowel SyndromeConstipation - FunctionalConstipationConstipation by Outlet Obstruction
- Interventions
- Other: Standard Physical Therapy CareOther: Aerobic and Inspiratory Muscle Training
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- University of Miami
- Registration Number
- NCT05321953
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Phase 2
Completed
- Conditions
- Chemotherapy-induced Nausea and Vomiting
- Interventions
- Drug: Standard of Care Treatment for Chemotherapy Induced Nausea and Vomiting (CINV)Drug: Aromatherapy Care
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 100
- Registration Number
- NCT05319860
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Pain and Hysteroscopy
Not Applicable
Completed
- Conditions
- Hysteroscopy Surgery
- Interventions
- Other: Objective Descriptive LanguageOther: Anticipated Discomfort Language
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 70
- Registration Number
- NCT05316506
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Phase 2
Recruiting
- Conditions
- Marginal Zone Lymphoma
- Interventions
- Drug: Loncastuximab tesirine 150 µg/KgDrug: Loncastuximab tesirine 75µg/Kg
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 50
- Registration Number
- NCT05296070
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States
🇺🇸City of Hope National Medical Center, Duarte, California, United States
Exercise Induced Hypoalgesia Diabetes
Not Applicable
Withdrawn
- Conditions
- Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathy
- Interventions
- Other: Moderate CyclingOther: Personalized Tourniquet System
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- University of Miami
- Registration Number
- NCT05296642
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
Phase 3
Completed
- Conditions
- Total Hip ReplacementTotal Knee Replacement
- Interventions
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 223
- Registration Number
- NCT05291598
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
Not Applicable
Recruiting
- Conditions
- Recurrent Glioblastoma
- Interventions
- Radiation: Intensity Modulated Proton Therapy (IMPT)
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 96
- Registration Number
- NCT05284643
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath